136 related articles for article (PubMed ID: 37103947)
1. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
Jaye DL; Feldman AL
Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
[No Abstract] [Full Text] [Related]
2. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
Boddicker RL; Feldman AL
Biomark Med; 2015; 9(8):719-22. PubMed ID: 26223379
[No Abstract] [Full Text] [Related]
3. Genetics of anaplastic large cell lymphoma.
Zeng Y; Feldman AL
Leuk Lymphoma; 2016; 57(1):21-7. PubMed ID: 26104084
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement.
Khanlari M; Tang G; Hao S; Gong Y; Li S; Miranda RN; Lin P; Iyer S; Yin CC; Xie W; Vega F; Medeiros LJ; Xu J
Br J Haematol; 2021 Jan; 192(1):e17-e21. PubMed ID: 33216956
[No Abstract] [Full Text] [Related]
5. PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.
Arun I; Roy P; Arora N; Bhave SJ; Nair R; Chandy M
Int J Surg Pathol; 2017 Jun; 25(4):333-338. PubMed ID: 28013563
[TBL] [Abstract][Full Text] [Related]
6. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
[TBL] [Abstract][Full Text] [Related]
8. BCL-3 overexpression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Rassidakis GZ; Oyarzo MP; Medeiros LJ
Blood; 2003 Aug; 102(3):1146-7. PubMed ID: 12869493
[No Abstract] [Full Text] [Related]
9. JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology.
Fitzpatrick MJ; Massoth LR; Marcus C; Vergilio JA; Severson E; Duncan D; Ramkissoon SH; Hasserjian RP; Kim AS; Sohani AR; Williams EA; Nardi V
Am J Surg Pathol; 2021 Jul; 45(7):895-904. PubMed ID: 34105517
[TBL] [Abstract][Full Text] [Related]
10. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
Parrilla Castellar ER; Jaffe ES; Said JW; Swerdlow SH; Ketterling RP; Knudson RA; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Vasmatzis G; Gibson SE; Ondrejka S; Nicolae A; Grogg KL; Allmer C; Ristow KM; Wilson WH; Macon WR; Law ME; Cerhan JR; Habermann TM; Ansell SM; Dogan A; Maurer MJ; Feldman AL
Blood; 2014 Aug; 124(9):1473-80. PubMed ID: 24894770
[TBL] [Abstract][Full Text] [Related]
11. Leukemic phase of ALK-positive anaplastic large cell lymphoma.
He R; Viswanatha DS
Blood; 2013 Mar; 121(11):1934. PubMed ID: 23610781
[No Abstract] [Full Text] [Related]
12. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.
Yee HT; Ponzoni M; Merson A; Goldstein M; Scarpa A; Chilosi M; Menestrina F; Pittaluga S; de Wolf-Peeters C; Shiota M; Mori S; Frizzera G; Inghirami G
Blood; 1996 Feb; 87(3):1081-8. PubMed ID: 8562933
[TBL] [Abstract][Full Text] [Related]
13. Molecular Screening in Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling.
Kalinova M; Mrhalova M; Kabickova E; Svaton M; Skotnicova A; Prouzova Z; Krenova Z; Kolenova A; Divoka M; Fronkova E; Kodet R
Mod Pathol; 2024 Mar; 37(3):100428. PubMed ID: 38266918
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
[TBL] [Abstract][Full Text] [Related]
15. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
Irshaid L; Xu ML
Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
[TBL] [Abstract][Full Text] [Related]
16. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
Waggott W; Lo YM; Bastard C; Gatter KC; Leroux D; Mason DY; Boultwood J; Wainscoat JS
Br J Haematol; 1995 Apr; 89(4):905-7. PubMed ID: 7772531
[TBL] [Abstract][Full Text] [Related]
17. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.
Lamant L; Meggetto F; al Saati T; Brugières L; de Paillerets BB; Dastugue N; Bernheim A; Rubie H; Terrier-Lacombe MJ; Robert A; Rigal F; Schlaifer D; Shiuta M; Mori S; Delsol G
Blood; 1996 Jan; 87(1):284-91. PubMed ID: 8547653
[TBL] [Abstract][Full Text] [Related]
18. RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large-cell lymphoma.
Ahmed N; Ketterling RP; Nowakowski GS; Dasari S; Feldman AL
Histopathology; 2022 Aug; 81(2):275-278. PubMed ID: 35586895
[No Abstract] [Full Text] [Related]
19. Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive.
Ahrendsen JT; Ta R; Li J; Weinberg OK; Ferry JA; Hasserjian RP; Meredith DM; Varma H; Sadigh S; Michaels PD
Am J Clin Pathol; 2022 Aug; 158(2):300-310. PubMed ID: 35460414
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib.
Reed DR; Hall RD; Gentzler RD; Volodin L; Douvas MG; Portell CA
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e247-e250. PubMed ID: 30992232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
